Interaction of α 1D-Adrenergic and P2X 7 Receptors in the Rat Lacrimal Gland and the Effect on Intracellular [Ca 2+α] and Protein Secretion

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 8, 2011, Pages 5720-5729

  Dartt, Darlene A ^a   Hodges, Robin R ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 1D ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; PEROXIDASE; PROTEIN KINASE C; PURINERGIC P2X7 RECEPTOR; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; A 438079; A-438079; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRUG DERIVATIVE; PHENYLEPHRINE; PIPERAZINE DERIVATIVE; PURINERGIC P2X RECEPTOR AGONIST; PURINERGIC P2X RECEPTOR ANTAGONIST; PYRIDINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ACINAR CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; LACRIMAL GLAND; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RAT; SPECTROPHOTOMETRY; ANIMAL; DRUG EFFECT; IN VITRO STUDY; LACRIMAL APPARATUS; LACRIMAL FLUID; METABOLISM; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; LACRIMAL APPARATUS; MALE; PHENYLEPHRINE; PIPERAZINES; PROTEIN KINASE C; PURINERGIC P2X RECEPTOR AGONISTS; PURINERGIC P2X RECEPTOR ANTAGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR CROSS-TALK; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION; TEARS; TETRAZOLES;

EID: 80053301466     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7358     Document Type: Article

References (24)

1. Dartt DA. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res. 2009;28:155-177.
2. Dartt DA, Baker AK, Vaillant C, Rose PE. Vasoactive intestinal polypeptide stimulation of protein secretion from rat lacrimal gland acini. Am J Physiol. 1984;247(pt 1):G502-G509.
3. Dartt DA, Dicker DM, Ronco LV, Kjeldsen IM, Hodges RR, Murphy SA. Lacrimal gland inositol trisphosphate isomer and inositol tetrakisphosphate production. Am J Physiol. 1990;259(pt 1):G274-G281.
4. Hodges RR, Dicker DM, Rose PE, Dartt DA. Alpha 1-adrenergic and cholinergic agonists use separate signal transduction pathways in lacrimal gland. Am J Physiol. 1992;262(pt 1):G1087-G1096.
5. Zoukhri D, Hodges RR, Sergheraert C, Toker A, Dartt DA. Lacrimal gland PKC isoforms are differentially involved in agonist-induced protein secretion. Am J Physiol. 1997;272(pt 1):C263-C269.
6. Hodges RR, Shatos MA, Tarko RS, Vrouvlianis J, Gu J, Dartt DA. Nitric oxide and cGMP mediate alpha1D-adrenergic receptor-stimulated protein secretion and p42/p44 MAPK activation in rat lacrimal gland. Invest Ophthalmol Vis Sci. 2005;46:2781-2789.
7. Chen L, Hodges RR, Funaki C, et al. Effects of alpha1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells. Am J Physiol Cell Physiol. 2006;291: C946-C956.
8. Ota I, Zoukhri D, Hodges RR, et al. Alpha 1-adrenergic and cholinergic agonists activate MAPK by separate mechanisms to inhibit secretion in lacrimal gland. Am J Physiol Cell Physiol. 2003;284: C168-C178.
9. Hodges RR, Guilbert E, Shatos MA, Natarajan V, Dartt DA. Phospholipase D1, but not D2, regulates protein secretion via Rho/ ROCK in a Ras/ Raf-independent, MEK-dependent manner in rat lacrimal gland. Invest Ophthalmol Vis Sci. 2011;52:2199-2210.
10. Zoukhri D, Dartt DA. Cholinergic activation of phospholipase D in lacrimal gland acini is independent of protein kinase C and calcium. Am J Physiol. 1995;268(pt 1):C713-C720.
11. Hodges RR, Zoukhri D, Sergheraert C, Zieske JD, Dartt DA. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components. Invest Ophthalmol Vis Sci. 1997;38:610-619.
12. Hodges RR, Vrouvlianis J, Shatos MA, Dartt DA. Characterization of P2X7 purinergic receptors and their function in rat lacrimal gland. Invest Ophthalmol Vis Sci. 2009;50:5681-5689.
13. Dartt DA, Hodges RR. Cholinergic agonists activate P2X7 receptors to stimulate protein secretion by the rat lacrimal gland. Invest Ophthalmol Vis Sci. 2011;52:3381-3390.
14. 2+. Am J Physiol Cell Physiol. 2009;297:C28-C42.
15. Decker DA, Galligan JJ. Cross-inhibition between nicotinic acetylcholine receptors and P2X receptors in myenteric neurons and HEK-293 cells. Am J Physiol Gastrointest Liver Physiol. 2009;296: G1267-G1276.
16. Barajas-Lopez C, Espinosa-Luna R, Zhu Y. Functional interactions between nicotinic and P2X channels in short-term cultures of guinea-pig submucosal neurons. J Physiol. 1998;513(pt 3):671-683.
17. Kim M, Jiang LH, Wilson HL, North RA, Surprenant A. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 2001;20:6347-6358.
18. Michel AD, Chambers LJ, Walter DS. Negative and positive allosteric modulators of the P2X(7) receptor. Br J Pharmacol. 2008;153: 737-750.
19. Brown DA, Yule DI. Protein kinase C regulation of P2X3 receptors is unlikely to involve direct receptor phosphorylation. Biochim Biophys Acta. 2007;1773:166-175.
20. Roger S, Gillet L, Baroja-Mazo A, Surprenant A, Pelegrin P. C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J Biol Chem. 2010;285: 17514-17524.
21. Iglesias R, Locovei S, Roque A, et al. P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol. 2008;295:C752-C760.
22. 2+ signaling in mouse lacrimal acinar cells. J Biol Chem. 1996;271:6766-6770.
23. Sladek CD, Song Z. Regulation of vasopressin release by co-released neurotransmitters: mechanisms of purinergic and adrenergic synergism. Prog Brain Res. 2008;170:93-107.
24. Gomes DA, Song Z, Stevens W, Sladek CD. Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors. Am J Physiol Regul Integr Comp Physiol. 2009;297: R940-R949.